» Articles » PMID: 14959716

Bioethics, Vulnerability, and Protection

Overview
Journal Bioethics
Specialty Medical Ethics
Date 2004 Feb 13
PMID 14959716
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

What makes individuals, groups, or even entire countries vulnerable? And why is vulnerability a concern in bioethics? A simple answer to both questions is that vulnerable individuals and groups are subject to exploitation, and exploitation is morally wrong. This analysis is limited to two areas. First is the context of multinational research, in which vulnerable people can be exploited even if they are not harmed, and harmed even if they are not exploited. The type of multinational research likely to raise the most ethical concerns is that in which the investigators or sponsors are from a powerful industrialised country or a giant pharmaceutical company and the research is conducted in a developing country. Second is the situation of women, who are made vulnerable in cultural settings or in entire countries in which they are oppressed and powerless. In the face of cultural values and practices, or governmental policies, these women suffer serious consequences for their health and even lives. Examples are provided, and it is suggested that in some cases vulnerable individuals can be harmed but not exploited. On the positive side, recent developments reveal a new awareness of exploitation and efforts to enhance the ability of developing countries to protect themselves and their citizens from exploitation at the hands of powerful sponsors of research. In addition, human rights principles are increasingly being used to monitor the actions (or inaction) of governments regarding women's reproductive rights and vulnerability with respect to HIV/AIDS, and to take remedial actions.

Citing Articles

Vulnerable Research Participant Policies at U.S. Academic Institutions.

Jonathan I, Akers E, Shi M, Resnik D J Empir Res Hum Res Ethics. 2024; 19(4-5):220-225.

PMID: 39420680 PMC: 11588538. DOI: 10.1177/15562646241290093.


Who to engage in HIV vaccine trial benefit-sharing negotiations? An empirical proposition of a framework.

Pancras G, Ezekiel M, Mbugi E, Merz J BMC Med Ethics. 2024; 25(1):54.

PMID: 38745276 PMC: 11092097. DOI: 10.1186/s12910-024-01058-4.


Ethical Considerations in Research With People From Refugee and Asylum Seeker Backgrounds: A Systematic Review of National and International Ethics Guidelines.

Davidson N, Hammarberg K, Fisher J J Bioeth Inq. 2023; 21(2):261-284.

PMID: 37889418 PMC: 11289226. DOI: 10.1007/s11673-023-10297-w.


Vulnerability in Biomedical Research: A Historical Reflection and Practical Implications for HIV Cure-Related Research.

Rao E, Taylor J, Kaytes A, Concha-Garcia S, Riggs P, Smith D AIDS Res Hum Retroviruses. 2023; 40(1):22-27.

PMID: 37227023 PMC: 10790546. DOI: 10.1089/AID.2022.0136.


Bioethical Implications of Vulnerability and Politics for Healthcare in Ethiopia and The Ways Forward.

Mussie K, Elger B, Kaba M, Pageau F, Wienand I J Bioeth Inq. 2022; 19(4):667-681.

PMID: 36136221 PMC: 9908630. DOI: 10.1007/s11673-022-10210-x.